This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Dana-Farber-Cancer Institute Inc., Massachusetts Institute of Technology, The Brigham and Women's Hospital, Inc.. Active years: 2024.
Company Filing History:
1 out of 1,265 
1 out of 8,576 
1 out of 1,424 
Years Active: 2024
Title: Davide Mangani: Innovator in Cancer Research
Introduction
Davide Mangani is a notable inventor based in Boston, MA, who has made significant contributions to the field of cancer research. His work focuses on enhancing anti-tumor immunity through innovative methods and compositions that modulate cell interactions and signaling within the tumor microenvironment.
Latest Patents
Mangani holds a patent for "Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment." This invention aims to identify interacting cells in the tumor microenvironment and utilize these interactions to boost anti-tumor immunity in cancer patients. The patent outlines how identified interactions can be modulated using therapeutic agents, and it discusses the use of immune cells resistant to suppression for adoptive cell transfer. Additionally, the invention addresses cell types and genes correlated with tumor growth and size.
Career Highlights
Throughout his career, Davide Mangani has worked with prestigious organizations, including the Dana-Farber Cancer Institute and the Broad Institute. His research has contributed to advancements in understanding cancer biology and developing new therapeutic strategies.
Collaborations
Mangani has collaborated with esteemed colleagues such as Meromit Singer and Aviv Regev, further enhancing the impact of his research in the scientific community.
Conclusion
Davide Mangani's innovative work in cancer research exemplifies the importance of understanding cell interactions in the tumor microenvironment. His contributions through patents and collaborations continue to pave the way for advancements in cancer treatment.